Kindstar Globalgene Technology, Inc. (HKG:9960)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
1.210
-0.010 (-0.82%)
Jan 30, 2026, 4:08 PM HKT

Kindstar Globalgene Technology Company Description

Kindstar Globalgene Technology, Inc., an investment holding company, provides clinical testing services in the People’s Republic of China.

The company offers its esoteric testing services for hematology, genetic diseases, gynecology, infectious diseases, neurology, and oncology diseases.

It also provides testing services for the early warning, prevention, diagnosis, selection of therapeutic schedules, and evaluation for curative effect of specialized diseases.

The company’s lab platforms comprise flow cytometry, cytogenetic, medical genomics, molecular biology, hematopathology, mass spectrum, pathology, clinical immunology, microbiology, and scientific research testing laboratories.

The company was founded in 2003 and is headquartered in Wuhan, the People’s Republic of China.

Kindstar Globalgene Technology, Inc.
CountryCayman Islands
Founded2003
IndustryDiagnostics & Research
SectorHealthcare
Employees3,162
CEOShiang Huang

Contact Details

Address:
Biolake D2-1
Wuhan
China
Phone400-736-1666
Websitekindstar.com.cn

Stock Details

Ticker Symbol9960
ExchangeHong Kong Stock Exchange
Fiscal YearJanuary - December
Reporting CurrencyCNY
ISIN NumberKYG5262E1044
SIC Code8071

Key Executives

NamePosition
Dr. Shiang Huang M.D.Founder, Executive Chairman, Chief Executive Officer and Chief Medical Officer
Zanbing Tu M.B.A.Co-Founder, Executive Director and Chief Operating Officer
Haijie ChaiExecutive Director, Chief Financial Officer and Company Secretary
Dr. Fan Jian-Bing Ph.D.Chief Scientific Officer